Where future emerging pathogens will come from and what approaches can be used to find them, besides VFARs

Journal of Water and Health

Volumn 7, Issue SUPPL. 1, 2009, Pages

  Sobsey, Mark D ^a   Pillai, Suresh D ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; Emerging pathogens; Microbial ecology; Surveillance; Virulence; Zoonoses

Indexed keywords

ANTIBIOTIC RESISTANCE; COMMENSAL; EMERGENCE; EPIDEMIOLOGY; HEALTH IMPACT; HOST-PATHOGEN INTERACTION; IMMUNE SYSTEM; INFECTIOUS DISEASE; MICROBIAL ECOLOGY; PATHOGENICITY; PUBLIC HEALTH; VIRULENCE;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; CHOLERA; COMMENSAL; GENOME; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE STATUS; INFLUENZA; INFLUENZA VIRUS; MICROBIAL DIVERSITY; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; REVIEW; VIBRIO CHOLERAE;

BACTERIA; BACTERIAL INFECTIONS; COMMUNICABLE DISEASES, EMERGING; HUMANS; VIRULENCE; VIRULENCE FACTORS; VIRUS DISEASES; VIRUSES; WATER MICROBIOLOGY;

EID: 77949372217     PISSN: 14778920     EISSN: None     Source Type: Journal    
DOI: 10.2166/wh.2009.096     Document Type: Review

References (118)

1. Aarestrup, F. M., Bager, F., Jensen, N. E., Madsen, M., Meyling, A. & Wegener, H. C. 1998 Resistance to antimicrobial agents used for animal therapy in pathogenic-, zoonotic- and indicator bacteria isolated from different food animals in Denmark: a baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP). Apmis 106, 745-770.
2. Ahl, A. S. & Buntain, B. 1997 Risk and the food safety chain: animal health, public health and the environment. Rev. Sci. Technol. 16(2), 322-330.
3. Alam, M., Sultana, M., Nair, G. B., Siddique, A. K., Hasan, N. A., Sack, R. B., Sack, D. A., Ahmed, K. U., Watanabe, A. S. H., Grim, C. J., Huq, A. & Colwell, R. R. 2007 Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission. Proc. Natl Acad. Sci. USA 104(45), 17801-17806.
4. Alexander, D. J. 2006 Avian influenza viruses and human health. Dev. Biol (Basel) 124, 77-84.
5. Alexander, D. J. & Brown, I. H. 2000 Recent zoonoses caused by influenza A viruses. Rev. Sci. Technol. 19(1), 197-225.
6. Anderson, M. E. & Sobsey, M. D. 2006 Detection and occurrence of antimicrobially resistant E. coli in groundwater on or near swine farms in eastern North Carolina. Water Sci. Technol. 54(3), 211-218.
7. Bansal, T., Jesudhasan, P., Pillai, S., Wood, T. K. & Jayaraman, A. 2008 Temporal regulation of enterohemorrhagic Escherichia coli virulence mediated by autoinducer-2. Appl. Microbiol. Biotechnol. 78, 811-819.
8. Baranowski, E., Ruiz-Jarabo, C. M. & Domingo, E. 2001 Evolution of cell recognition by viruses. Science 292, 1102-1105.
9. Belay, E. D., Maddox, R. A., Williams, E. S., Miller, M. W., Gambetti, P. & Schonberger, L. B. 2004 Chronic wasting disease and potential transmission to humans. Emerg. Infect. Dis. 10(6), 977-984.
10. Blake, P. A. 1983 Vibrios on the half shell: what the walrus and the carpenter didn't know. Ann. Internal Med. 99(4), 558-559.
11. Blake, P. A., Rosenberg, M. L., Florencia, J., Costa, J. B., do Prado Quintino, L. & Gangarosa, E. J. 1977 Cholera in Portugal, 1974. II. Transmission by bottled mineral water. Am. J. Epidemiol. 105(4), 344-348.
12. Braoudaki, M. & Hilton, A. C. 2004 Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and crossresistance to antimicrobial agents. J. Clin. Microbiol. 42(1), 73-78.
13. Braoudaki, M. & Hilton, A. C. 2005 Mechanisms of resistance in Salmonella enterica adapted to erythromycin, benzalkonium chloride and triclosan. Int. J. Antimicrob. Agents 25(1), 31-37.
14. Cabello, F. C. 2006 Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ. Microbiol. 8(7), 1137-1144.
15. Cha, J., Kotra, L. P. & Mobashery, S. 2008 Resistance to betalactam antibiotics mediated by beta-lactamases: structure, mechanism and evolution. In Bacterial Resistance to Antimicrobials, 2nd edition. (ed. R. G. Wax, K. Lewis, A. Salyers & H. Taber), pp. 103-132. CRC Press, Boca Raton, FL, Ch. 6.
16. Cheng, V. C., Lau, S. K., Woo, P. C. & Yuen, K. Y. 2007 Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 20(4), 660-694.
17. Childers, B. M. & Klose, K. E. 2007 Regulation of virulence in Vibrio cholerae: the ToxR regulon. Future Microbiol. 2, 335-344.
18. Cole, D. J., Hill, V. R., Humenik, F. J. & Sobsey, M. D. 1999 Health, safety and environmental concerns of farm animal waste, occupational medicine. In Occupational Medicine State of the Arts Reviews. Animal Handlers (ed. R. Langley), pp. 423-448. Hanley and Belfus, Inc., Philadelphia.
19. Colwell, R. R. 1996 Global climate and infectious disease: the cholera paradigm. Science 274(5295), 2025-2031.
20. Colwell, R. R. 2004 Infectious disease and environment: cholera as a paradigm for waterborne disease. Int. Microbiol. 7(4), 285-289.
21. Corcoran, A. & Doyle, S. 2004 Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J. Med. Microbiol. 53, 459-475.
22. Davis, B. M. & Waldor, M. K. 2003 Filamentous phages linked to virulence of Vibrio cholerae. Curr. Opin. Microbiol. 6, 35-42.
23. De Jesus, N. H. 2007 Epidemics to eradication: the modern history of poliomyelitis. Virol. J. 4, 70.
24. Doherr, M. G. 2003 Bovine spongiform encephalopathy (BSE)-infectious, contagious, zoonotic or production disease? Acta Vet. Scand. Suppl. 44(S1), S33-S42.
25. Eberhard, M. L. & Arrowood, M. J. 2002 Cyclospora spp. Curr. Opin. Infect. Dis. 15(5), 519-522.
26. Emch, M., Feldacker, C., Islam, M. S. & Ali, M. 2008 Seasonality of cholera from 1974 to 2005: a review of global patterns. Int. J. Health Geogr. 7, 31.
27. Enriquez, C., Nwachuku, N. & Gerba, C. P. 2001 Direct exposure to animal enteric pathogens. Rev. Environ. Health 16(2), 117-131.
28. Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K. & Maizel, J. V. 1985 Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314, 548-550.
29. Fabiano, L., Thompson, F. L., Iida, T. & Swings, J. 2004 Biodiversity of Vibrios. Microbiol. Mol. Biol. Rev. 68(3), 403-431.
30. Fallon, B. A., Nields, J. A., Parsons, B., Liebowitz, M. R. & Klein, D. F. 1993 Psychiatric manifestations of Lyme borreliosis. J. Clin. Psychiatry 54, 263-268.
31. Faruque, S. M. & Mekalanos, J. J. 2003 Pathogenicity islands and phages in Vibrio cholerae evolution. Trends Microbiol. 11(11), 505-510.
32. Faruque, S. M., Albert, M. J. & Mekalanos, J. J. 1998 Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol. Mol. Biol. Rev. 62(4), 1301-1314.
33. Faruque, S. M., Chowdhury, N., Kamruzzaman, M., Dziejman, M., Rahman, M. H., Sack, D. A., Nair, G. B. & Mekalanos, J. J. 2004 Genetic diversity and virulence potential of environmental Vibrio cholerae population in a choleraendemic area. Proc. Natl Acad. Sci. USA 101(7), 2123-2128.
34. Faruque, S. M., Biswas, K., Udden, S. M. N., Ahmad, Q. S., Sack, D. A., Nair, G. B. & Mekalanos, J. J. 2006 Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment. Proc. Natl Acad. Sci. USA 103(1), 6350-6355.
35. Finelli, L., Swerdlow, D., Mertz, K., Ragazzoni, H. & Spitalny, K. 1992 Outbreak of cholera associated with crab brought from an area with epidemic disease. J. Infect. Dis. 166(6), 1433-1435.
36. Gerba, C. P. & Smith, J. E. Jr. 2005 Sources of pathogenic microorganisms and their fate during land application of wastes. J. Environ. Qual. 34(1), 42-48.
37. Girennavar, B., Cepeda, M. L., Soni, K. A., Vikram, A., Jesudhasan, P., Jayaprakasha, G. K., Pillai, S. D. & Patil, B. S. 2008 Grapefruit juice and its furocoumarins inhibits autoinducer signaling and biofilm formation in bacteria. Int. J. Food Microbiol. 125, 204-208.
38. Guerrant, R. L. 1994 Twelve messages from enteric infections for science and society. Am. J. Trop. Med. Hyg. 51(1), 26-35.
39. Guerrant, R. L., Carneiro-Filho, B. A. & Dillingham, R. A. 2003 Cholera, diarrhea, and oral rehydration therapy: triumph and indictment. Clin. Infect. Dis. 37(3), 398-405.
40. Halperin, T., Vennema, H., Koopmans, M., Kahila Bar-Gal, G., Kayouf, R., Sela, T., Ambar, R. & Klement, E. 2008 No association between histo-blood group antigens and susceptibility to clinical infections with genogroup II norovirus. J. Infect. Dis. 197(1), 63-65.
41. Hampson, A. W. & Mackenzie, J. S. 2006 The influenza viruses. Med. J. Aust. 185(Suppl. 10), S39-S43.
42. Hawkey, P. M. 2008 The growing burden of antimicrobial resistance. J. Antimicrob. Chemother. 62, i1-i9.
43. Heidelberg, J. F., Eisen, J. A., Nelson, W. C., Clayton, R. A., Gwinn, M. L., Dodson, R. J., Haft, D. H., Hickey, E. K., Peterson, J. D., Umayam, L., Gill, S. R., Nelson, K. E., Read, T. D., Tettelin, H., Richardson, D., Ermolaeva, M. D., Vamathevan, J., Bass, S., Qin, H., Dragoi, I., Sellers, P., McDonald, L., Utterback, T., Fleishmann, R. D., Nierman,W. C., White, O., Salzberg, S. L., Smith, H. O., Colwell, R. R., Mekalanos, J. J., Venter, J. C. & Fraser, C. M. 2000 DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406(6795), 477-483.
44. Hilleman, M. R. 2002 Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20(25-26), 3068-3087.
45. Huang, P., Farkas, T., Zhong, W., Tan, M., Thornton, S., Morrow, A. L. & Jiang, X. 2005 Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79(11), 6714-6722.
46. Hutson, A. M., Atmar, R. L. & Estes, M. K. 2004 Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 12(6), 279-287.
47. Jiang, P., Faze, J. A. J., Toyoda, H., Paul, A., Wimmer, E. & Gorbalenya, A. E. 2007 Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication. Proc. Natl Acad. Sci. USA 104(22), 9457-9462.
48. Kaper, J. B., Morris, J. G. Jr. & Levine, M. M. 1995 Cholera. Clin. Microbiol. 8(1), 48-86.
49. Karanja, R. M., Gatei, W. & Wamae, N. 2007 Cyclosporiasis: an emerging public health concern around the world and in Africa. Afr. Health Sci. 7(2), 62-67.
50. Kew, O. & Miyamura, T. 2004 Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J. Virol. 78(24), 13512-13521.
51. Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., Andre, J., Blackman, E., Freeman, C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L., Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T., Miyamura, T., van Der Avoort, H., Oberste, M. S., Kilpatrick, D., Cochi, S., Pallansch, M. & de Quadros, C. 2002 Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296(5566), 356-359.
52. Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N. & Pallansch, M. A. 2004 Circulating vaccinederived polioviruses: current state of knowledge. Bull. World Health Organ. 82(1), 16-23.
53. Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R. & Pallansch, M. A. 2005 Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann. Rev. Microbiol. 59, 587-635.
54. Khare, S., Ficht, T. A., Santos, R. L., Romano, J., Ficht, A. R., Zhang, S., Grant, I. R., Libal, M., Hunter, D. & Adams, L. G. 2004 Rapid and sensitive detection of Mycobacterium avium subsp. paratuberculosis in bovine milk and feces by a combination of immunomagnetic bead separation-conventional PCR and realtime PCR. J. Clin. Microbiol. 42, 1075-1081.
55. Landolt, G. A. & Olsen, C. W. 2007 Up to new tricks-a review of cross-species transmission of influenza A viruses. Anim. Health Res. Rev. 8(1), 1-21.
56. Lars, T. & Ulrik-Fredrik, M. 2001 Personality and physical symptoms in nonpsychiatric patients with functional gastrointestinal disorder. J. Psychosom. Res. 50, 139-146.
57. Lentz, T. L. 1990 The recognition event between virus and host cell receptor: a target for antiviral agents. J. Gen. Virol. 71, 751-766.
58. Kilbourne, E. D. 2006 Influenza pandemics of the 20th century. Emerg. Infect. Dis. 12(1), 9-14.
59. Kim, S. & Aga, D. S. 2007 Potential ecological and human health impacts of antibiotics and antibiotic-resistant bacteria from wastewater treatment plants. J. Toxicol. Environ. Health B Crit. Rev. 10(8), 559-573.
60. Korteweg, C. & Gu, J. 2008 Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172(5), 1155-1170.
61. Lindesmith, L., Moe, C., Lependu, J., Frelinger, J. A., Treanor, J. & Baric, R. S. 2005 Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 79, 2900-2909.
62. Lindesmith, L. C., Donaldson, E. F., Lobue, A. D., Cannon, J. L., Zheng, D. P., Vinje, J. & Baric, R. S. 2008 Mechanisms of GII. 4 norovirus persistence in human populations. PLoS Med. 5(2), e31.
63. Mathew, A. G., Cissell, R. & Liamthong, S. 2007 Antibiotic resistance in bacteria associated with food animals: a United States perspective of livestock production. Foodborne Pathog. Dis. 4(2), 115-133.
64. McCarthy, S. A. & Khambaty, F. M. 1994 International dissemination of epidemic Vibrio cholerae by cargo ship ballast and other nonpotable waters. Appl. Environ. Microbiol. 60(7), 2597-2601.
65. McKinney, K. R., Gong, Y. Y. & Lewis, T. G. 2006 Environmental transmission of SARS at Amoy Gardens. J. Environ. Health 68(9), 26-30.
66. McKintosh, E., Tabrizi, S. J. & Collinge, J. 2003 Prion diseases. J. Neurovirol. 9, 183-193.
67. Minor, P. D. 1999 Poliovirus vaccination: current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis. Expert Rev. Mol. Med. 1(13), 1-17.
68. MMWR 1991a Epidemiologic notes and reports cholera-New Jersey and Florida. MMWR, May 3 40(17), 287-289.
69. MMWR 1991b Cholera associated with imported frozen coconut milk-Maryland. MMWR, December 13 40(49), 844-845.
70. MMWR 1992 Cholera associated with international travel. MMWR, September 11 41(36), 664-667.
71. Morens, D. M. & Fauci, A. S. 2007 The 1918 influenza pandemic: insights for the 21st century. J. Infect Dis. 195(7), 1018-1028.
72. Mueller, S., Wimmer, E. & Cello, J. 2005 Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res. 111(2), 175-193.
73. Naser, S. A., Schwartz, D. & Shafran, I. 2000 Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am. J. Gastroenterol. 95, 1094-1095.
74. Nathanson, N. 2008 The pathogenesis of poliomyelitis: what we don't know. Adv. Virus Res. 71, 1-50.
75. Nguyen-Van-Tam, J. S. & Sellwood, C. 2007 Avian influenza and the threat of the next human pandemic. J. Hosp. Infect. 65(Suppl. 2), 10-13.
76. NRC 2001 Virulence-factor activity relationships. In Classifying Drinking Water Contaminants for Regulatory Consideration. Committee on Drinking Water Contaminants, Water Science and Technology Board, Board on Environmental Studies and Toxicology, National Research Council. National Academies Press, Washington, DC, pp. 143-207, Ch. 6.
77. Peiris, J. S., de Jong, M. D. & Guan, Y. 2007 Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev. 20(2), 243-267.
78. Piddock, L. J. 1999 Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58(Suppl. 2), 11-18.
79. Pollitzer, R. 1959 History of the disease. In Cholera (ed. R. Pollitzer), pp. 11-50. World Health Organization, Geneva, Switzerland.
80. Prusiner, S. B. 1991 Molecular biology of prion diseases. Science 252(5012), 1515-1522.
81. Racaniello, V. R. 2006 One hundred years of poliovirus pathogenesis. Virology 344(1), 9-16.
82. Reading, N. C. & Sperandio, V. 2005 Quorum sensing: the many languages of bacteria. FEMS Microbiol. Lett. 254, 1-11.
83. Ricketts, M. N. 2004 Public health and the BSE epidemic. Curr. Top. Microbiol. Immunol. 284, 99-119.
84. Rieder, E., Gorbalenya, A. E., Xiao, C., He, Y., Baker, T. S., Kuhn, R. J., Rossmann, M. G. & Wimmer, E. 2001 Will the polio niche remain vacant? Dev. Biol (Basel) 105(111-122), discussion 149-150.
85. Ries, A. A., Vugia, D. J., Beingolea, L., Palacios, A. M., Vasquez, E., Wells, J. G., Garcia Baca, N., Swerdlow, D. L., Pollack, M. & Bean, N. H. 1992 Cholera in Piura, Peru: a modern urban epidemic. J. Infect. Dis. 166(6), 1429-1433.
86. Roberts, M. C. 2004 Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics. Mol. Biotechnol. 28(1), 47-62.
87. Roberts, M. C. 2008 Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol. Lett. 282(2), 147-159.
88. Rossmann, M. G., He, Y. & Kuhn, R. J. 2002 Picornavirus-receptor interactions. Trends Microbiol. 10(7), 324-331.
89. Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclère, P. & Delpeyroux, F. 2003 Recombinant vaccine-derived poliovirus in Madagascar. Emerg. Infect. Dis. 9, 885-887.
90. Schlundt, J., Toyofuku, H., Jansen, J. & Herbst, S. A. 2004 Emerging food-borne zoonoses. Rev. Sci. Technol. 23(2), 513-533.
91. Shakya, T. & Wright, G. D. 2007 Mechanisms of aminoglycoside antibiotic resistance. In Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery (ed. D. P. Arya & B. Wang), pp. 119-140. John Wiley & Sons, New York, Ch. 3.
92. Shields, J. M. & Olson, B. H. 2003 Cyclospora cayetanensis: a review of an emerging parasitic coccidian. Int. J. Parasitol. 33(4), 371-391.
93. Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., Yoneyama, T., Benegas, A., Roesel, S. & Pallansch, M. 2004 Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J. Virol. 78, 13512-13521.
94. Sidhu, M. S., Heir, E., Sørum, H. & Holck, A. 2001 Genetic linkage between resistance to quaternary ammonium compounds and beta-lactam antibiotics in food-related Staphylococcus spp. Microb. Drug Resist. 7(4), 363-371.
95. Skovgaard, N. 2007 New trends in emerging pathogens. Int. J. Food Microbiol. 120(3), 217-224.
96. Slifko, T. R., Smith, H. V. & Rose, J. B. 2000 Emerging parasite zoonoses associated with water and food. Int. J. Parasitol. 30(12-13), 1379-1393.
97. Smith, P. G., Cousens, S. N., d'Huillard Aignaux, J. N., Ward, H. J. & Will, R. G. 2004 The epidemiology of variant Creutzfeldt-Jakob disease. Curr. Topics Microbiol. Immunol. 284, 161-191.
98. Solorzano, A., Song, H., Hickman, D. & Pérez, D. R. 2007 Pandemic influenza: preventing the emergence of novel strains and countermeasures to ameliorate its effects. Infect. Disord. Drug Targets 7(4), 304-317.
99. Soni, K., Jesudhasan, P. R., Cepeda, M. L., Williams, B., Hume, M., Russell, W. K., Jayaraman, A. & Pillai, S. D. 2008a Autoinducer AI-2 is involved in regulating a variety of cellular processes in Salmonella typhimurium. Foodborne Pathol. Dis. 5, 147-153.
100. Soni, K. A., Jesudhasan, P., Cepeda, M., Widmer, K., Jayaprakasha, G. K., Patil, B. S., Hume, M. E. & Pillai, S. D. 2008b Identification of ground beef-derived fatty acid inhibitors of autoinducer-2-based cell signaling. J. Food. Prot. 71, 134-138.
101. Soni, K. A., Lingeng, L., Jesudhasan, P. R., Hume, M. E. & Pillai, S. D. 2008c Influence of Autoinducer-2 (AI-2) and beef sample extracts on E. coli O157:H7 survival and gene expression of virulence genes yadK and hhA. J. Food Sci. 73, M135-M139.
102. St Louis, M. E., Porter, J. D., Helal, A., Drame, K., Hargrett-Bean, N., Wells, J. G. & Tauxe, R. V. 1990 Epidemic cholera in West Africa: the role of food handling and high-risk foods. Am. J. Epidemiol. 131(4), 719-728.
103. Swerdlow, D. L., Mintz, E. D., Rodriguez, M., Tejada, E., Ocampo, C., Espejo, L., Greene, K. D., Saldana, W., Seminario, L. & Tauxe, R. V. 1992 Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet 340(8810), 28-33.
104. Tantillo, G. M., Fontanarosa, M., Di Pinto, A. & Musti, M. 2004 Updated perspectives on emerging vibrios associated with human infections. Lett. Appl. Microbiol. 39, 117-126.
105. Tenover, F. C. 2006a Mechanisms of antimicrobial resistance in bacteria. Am. J. Infect. Control 34(5 Suppl. 1), S3-S10, discussion S64-73.
106. Tenover, F. C. 2006b Mechanisms of antimicrobial resistance in bacteria. Am. J. Med. 119(6 Suppl 1), S3-S10, discussion S62-70.
107. Threlfall, E. J. 2000 Epidemic Salmonella typhimurium DT 104-a truly international multiresistant clone. J. Antimicrob. Chemother. 46, 7-10.
108. Threlfall, E. J. 2002 Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol. Rev. 26(2), 141-148.
109. Torrey, E. F. & Yolken, R. H. 2001 The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav. Immun. 15, 401-410.
110. Walters, M. & Sperandio, V. 2006 Autoinducer 3 and epinephrine signaling in the kinetics of locus of enterocyte effacement gene expression in enterohemorrhagic Escherichia coli. Inf. Immun. 74, 5445-5455.
111. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M. & Kawaoka, Y. 1992 Evolution and ecology of influenza A viruses. Microbiol. Rev. 56(1), 152-179.
112. Webster, R. G., Krauss, S., Hulse-Post, D. & Sturm-Ramirez, K. 2007 Evolution of influenza A viruses in wild birds. J. Wildlife Dis. 43(Suppl. 3), S1-S6.
113. Widmer, K. W., Soni, K., Hume, M., Beier, R. C., Jesudhasan, P. & Pillai, S. D. 2007 Identification of poultry meat-derived fatty acids functioning as quorum sensing signal inhibitors to Autoinducer-2 (AI-2). J. Food Sci. 72, M363-M368.
114. World Health Organization 2004 Waterborne Zoonoses. Identification, Causes, and Control. In: Cotruvo, J. A., Dufour, A., Rees, G., Bartram, J., Carr, R., Cliver, D. O., Craun, G. F., Fayer, R. & Gannon, V. P. J (eds.) Published on behalf of the World Health Organization by IWA Publishing, London.
115. Yagupsky, P. 2004 Kingella kingae: from medical rarity to an emerging paediatric pathogen. Lancet Infect. Dis. 4, 358-367.
116. Yagupsky, P. 2006 Kingella kingae: an emerging pediatric pathogen. Adv. Exp. Med. Biol. 582, 179-190.
117. Yokoyama, T. & Mohri, S. 2008 Prion diseases and emerging prion diseases. Curr. Med. Chem. 15, 912-916.
118. Zhang, Y., Yan, D. M., Wang, D. Y., Zhao, R., Zhang, D. Y., Ye, X. F., Zhu, S. L., An, H. Q. & Xu, W. B. 2007 Reevaluate the effect of G-480 point mutation that determines the neurovirulence of type I vaccine polioviruses. Bing Du Xue Bao 23(1), 1-8.